Andreas Hetey

Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study

C. von Kalle, N. Suttorp, D. Treue, 2021, The Lancet Respiratory Medicine.

Reactogenicity of homologous and heterologous prime-boost immunization with BNT162b2 and ChAdOx1-nCoV19: a prospective cohort study

N. Suttorp, D. Treue, V. Corman, 2021, medRxiv.